Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy.

Related Articles Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy. Cancer Med. 2019 Sep;8(12):5554-5563 Authors: Huang PW, Chang CF, Hung CY, Hsueh SW, Chang PH, Yeh KY, Chen JS, Chen YY, Lu CH, Hung YS, Chou WC Abstract BACKGROUND: We previously developed a robust prognostic model (GS model) to predict the survival outcome of patients with advanced pancreatic cancer (APC) receiving palliative chemotherapy with gemcitabine plus S-1 (GS). This study aimed to validate the application of the GS model in APC patients receiving chemotherapy other than the GS regimen. PATIENTS AND METHODS:…
Origen: Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy. – PubMed